ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $3,033,000 | -27.9% | 75,049 | +2.7% | 0.01% | -25.0% |
Q2 2015 | $4,204,000 | -68.4% | 73,051 | -65.1% | 0.01% | -66.7% |
Q1 2015 | $13,322,000 | -94.4% | 209,242 | -94.6% | 0.02% | -94.2% |
Q4 2014 | $237,862,000 | -16.9% | 3,852,643 | -47.7% | 0.41% | -18.8% |
Q3 2014 | $286,119,000 | +9.7% | 7,368,499 | -2.7% | 0.51% | +13.3% |
Q2 2014 | $260,824,000 | -31.1% | 7,571,076 | -13.6% | 0.45% | -32.4% |
Q1 2014 | $378,596,000 | -11.8% | 8,761,769 | -18.7% | 0.67% | -13.5% |
Q4 2013 | $429,322,000 | +7.5% | 10,776,147 | +1.3% | 0.77% | +0.4% |
Q3 2013 | $399,190,000 | -99.8% | 10,633,737 | +16.0% | 0.77% | +45.3% |
Q2 2013 | $246,256,645,000 | – | 9,164,743 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|